For many people, the thought of a tasty burger or a cold pint of beer conjures up a vivid mental image and drives behaviour. This link between thinking and doing serves a clear function – it motivates ...
Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself.
Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...
Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results